TY  - GEN
AU  - Agathocleous,Agathoclis
AU  - Rohatiner,Ama
AU  - Rule,Simon
AU  - Hunter,Hannah
AU  - Kerr,Jonathan Paul
AU  - Neeson,Susan M
AU  - Matthews,Janet
AU  - Strauss,Sandra
AU  - Montoto,Silvia
AU  - Johnson,Peter
AU  - Radford,John
AU  - Lister,Andrew
TI  - Weekly versus twice weekly bortezomib given in conjunction with rituximab, in patients with recurrent follicular lymphoma, mantle cell lymphoma and Waldenström macroglobulinaemia
SN  - 1365-2141
PY  - 2011///0103
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Boronic Acids
KW  - Bortezomib
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Female
KW  - Hematologic Diseases
KW  - chemically induced
KW  - Humans
KW  - Lymphoma, Follicular
KW  - drug therapy
KW  - Lymphoma, Mantle-Cell
KW  - Lymphoproliferative Disorders
KW  - Male
KW  - Middle Aged
KW  - Pyrazines
KW  - Rituximab
KW  - Survival Analysis
KW  - Treatment Outcome
KW  - Waldenstrom Macroglobulinemia
N1  - Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1365-2141.2010.08340.x
ER  -